Literature DB >> 16266070

Stereotactic radiosurgery for spinal metastases from renal cell carcinoma.

Peter C Gerszten1, Steven A Burton, Cihat Ozhasoglu, William J Vogel, William C Welch, Joseph Baar, David M Friedland.   

Abstract

OBJECT: The role of stereotactic radiosurgery in treating renal cell carcinoma (RCC) metastases to the spine has previously been limited. In this study the authors evaluated the clinical outcome in patients with spinal RCC who underwent single-fraction radiosurgery.
METHODS: Forty-eight patients with 60 RCC metastases to the spine (six cervical, 26 thoracic, 18 lumbar, and 10 sacral) were treated with a single-fraction radiosurgery technique and were followed for a period of 14 to 48 months (median 37 months). All patients were successfully treated in an outpatient setting. The tumor volume ranged from 5.5 to 203 cm3 (mean 61.9 cm3). Forty-two of the total 60 lesions had been previously treated with external-beam radiation therapy (EBRT). The maximum tumor dose was maintained at 17.5 to 25 Gy (mean 20 Gy). The volume of the spinal cord exposed to greater than 8 Gy ranged from 0.01 to 3 cm3 (mean 0.64 cm3); the volume of the spinal canal at the cauda equina level exposed to greater than 8 Gy ranged from 0.01 to 2.2 cm3 (mean 0.65 cm3). No radiation-induced toxicity occurred during the follow-up period. Axial and radicular pain improved in 34 (89%) of 38 patients who were treated primarily for pain. Tumor control was demonstrated in seven of eight patients treated primarily for radiographically documented tumor progression. In time six patients required open surgical intervention for tumor progression that had caused neurological dysfunction after radiosurgery.
CONCLUSIONS: Spinal radiosurgery can be a successful therapeutic modality for the delivery of large-dose single-fraction radiation to RCC spinal metastases that are often poorly controlled with conventional EBRT modalities.

Entities:  

Mesh:

Year:  2005        PMID: 16266070     DOI: 10.3171/spi.2005.3.4.0288

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  43 in total

Review 1.  Image-guided intensity-modulated radiation therapy of spine tumors.

Authors:  Yoshiya Yamada; Michael Lovelock; Mark H Bilsky
Journal:  Curr Neurol Neurosci Rep       Date:  2006-05       Impact factor: 5.081

2.  Delayed vertebral body collapse after stereotactic radiosurgery and radiofrequency ablation: Case report with histopathologic-MRI correlation.

Authors:  Adam N Wallace; Ross Vyhmeister; Andy C Hsi; Clifford G Robinson; Randy O Chang; Jack W Jennings
Journal:  Interv Neuroradiol       Date:  2015-10-23       Impact factor: 1.610

Review 3.  Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach.

Authors:  Shankar Siva; Gargi Kothari; Alexander Muacevic; Alexander V Louie; Ben J Slotman; Bin S Teh; Simon S Lo
Journal:  Nat Rev Urol       Date:  2017-06-20       Impact factor: 14.432

4.  The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery.

Authors:  Yoshiya Yamada; Evangelia Katsoulakis; Ilya Laufer; Michael Lovelock; Ori Barzilai; Lily A McLaughlin; Zhigang Zhang; Adam M Schmitt; Daniel S Higginson; Eric Lis; Michael J Zelefsky; James Mechalakos; Mark H Bilsky
Journal:  Neurosurg Focus       Date:  2017-01       Impact factor: 4.047

5.  Radiotherapy for oligometastatic disease in patients with spinal cord compression (MSCC) from relatively radioresistant tumors.

Authors:  Katja Freundt; Thekla Meyners; Amira Bajrovic; Hiba Basic; Johann H Karstens; Irenaeus A Adamietz; Volker Rudat; Steven E Schild; Juergen Dunst; Dirk Rades
Journal:  Strahlenther Onkol       Date:  2010-03-26       Impact factor: 3.621

6.  Surgery and survival outcomes of 30 patients with neurological deficit due to clear cell renal cell carcinoma spinal metastases.

Authors:  Shuai Han; Ting Wang; Dongjie Jiang; Yang Yu; Yu Wang; Wangjun Yan; Wei Xu; Ming Cheng; Wang Zhou; Jianru Xiao
Journal:  Eur Spine J       Date:  2015-04-04       Impact factor: 3.134

7.  [Advantages of stereotactic body radiation vs. conventional radiation for spinal metastases].

Authors:  D Rades
Journal:  Strahlenther Onkol       Date:  2013-04       Impact factor: 3.621

8.  Answer to the Letter to the Editor of V. Bartanusz concerning "Surgery and survival outcomes of 30 patients with neurological deficit due to clear cell renal cell carcinoma spinal metastases" by Shuai Han, et al. (Eur Spine J, 2015; DOI 10.1007/s00586-015-3912-3).

Authors:  Jianru Xiao; Shuai Han; Ting Wang; Dongjie Jiang
Journal:  Eur Spine J       Date:  2016-03-14       Impact factor: 3.134

9.  [Value of postoperative stereotaxic body radiation therapy for spinal metastases].

Authors:  Dirk Rades
Journal:  Strahlenther Onkol       Date:  2017-02       Impact factor: 3.621

10.  The NOMS framework: approach to the treatment of spinal metastatic tumors.

Authors:  Ilya Laufer; David G Rubin; Eric Lis; Brett W Cox; Michael D Stubblefield; Yoshiya Yamada; Mark H Bilsky
Journal:  Oncologist       Date:  2013-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.